Exclusive Option AgreementExclusive Option Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
This Exclusive Option Agreement (this “Agreement”) is executed by and among the following Parties as of the 5th day of November, 2010 in Harbin, the People’s Republic of China (“China” or the “PRC”):
Equity Interest Pledge AgreementEquity Interest Pledge Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
This Equity Interest Pledge Agreement (this “Agreement”) has been executed by and among the following parties on November 5th, 2010 in Harbin, the People’s Republic of China (“China” or the “PRC”):
Harbin Yew Science and Technology Development Co., Ltd. Equity Transfer AgreementEquity Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
The registered capital of Harbin Yew Science and Technology Development Co., Ltd (hereinafter referred to as the “Target Company”) is RMB 45,000,000, among which, Party A’s capital contribution is RMB 8,340,000 and accounts for 18.53% of the total share capital. In accordance with relevant laws and regulations, the Parties reach the following agreement through negotiation in good faith:
Equity Transfer AgreementEquity Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
Party A holds 100% of the equity interest of Harbin Yew Science and Technology Development Co., Ltd (hereinafter referred to as the Company). Party A now contemplates to transfer 18.53% of the equity interest held by it to Party B. Party A and Party B reach the following agreement with respect to the transfer of equity interest aforementioned through negotiation in good faith on the basis of equally and mutual benefits:
CONSULTING AGREEMENTConsulting Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc. • Nevada
THIS CONSULTING AGREEMENT (this “Agreement”) is made and entered into as of November 1, 2010 (the “Effective Date”), by and between Yew Bio-Pharm Group, Ltd. (individually “YBP” and collectively with its wholly-owned subsidiaries, the “Company”) and Richard Lo (the “Consultant”). The parties (collectively, the “Parties”) hereto hereby agree as follows:
Barren Hills and Uncultivated Land Use Right Transfer AgreementLand Use Right Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
In order to exploit the use of Yew and develop the economy of Pingshan town, Pingshan town Government Beichuan Village (Party B) intends to transfer the deserted land of Beichuan Village to Hongdoushan Technology Development Corporation (Party A) for purpose of cultivation of Yew plants. The two sides have agreed on the following:
Joint-Stock Construct Rare Plant Northeast Yew ContractJoint-Stock Contract • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
In order to effectively cultivate and protect precious and rare plant Northeast yew resource and inspire enthusiasm of reforestation, cultivation and protection of the trees of all the society departments. Enhance pace development of forest industry and enhance the valuation and appreciation forest resources .Therefore, this contract was signed by us.
Waste Forest Land Transfer AgreementWaste Forest Land Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
Technology Development Services AgreementTechnology Development Services Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
This Technology Development Commission Agreement (this “Agreement”) is made and entered into by and between the following parties on January 1, 2010 in Haerbin.
Cooperation and Development Contract of Yew (taxus) YinpianCooperation and Development Contract • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
Party A is a legal company registered in China. The technology of artificial cultivation yew (taxus) legitimately owned by the company, which is the herb provider of artificial cultivation yew (taxus).
CONTRACT FOR THE TRANSFER OF FOREST LAND USE RIGHT AND OF THE OWNERSHIP OF TIMBERSContract for the Transfer of Forest Land Use Right and of the Ownership of Timbers • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
Through mutual negotiation, Party A agrees to transfer to Party B the forest land of 150 mu (250 mu in effect), the timber use right, the ownership of yew forest as well as the buildings on the north side of Dalizi Mountain.
Lease ContractLease Contract • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
Party A and Party B, through equal and voluntary negotiation, based on the principles of equal value exchange, enter into this Contract and promise to obey it.
CONTRACT FOR SEEDLING LANDContract for Seedling Land • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
In accordance with the Economic Contract Law of the People’s Republic of China and for the clarification of responsibilities and obligations of the two Parties, the Contract is hereby signed after negotiation between the two parties.
Lease ContractLease Contract • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
Technology Development Services Supplementary AgreementTechnology Development Services Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
In accordance with the terms and conditions of Technology Development Services Agreement signed on January 1, 2010 in Harbin, both sides supplement it as follows:
August 24, 2011 Mr. Wang Zhiguo Yew Bio Pharm Group Inc. Building 5, B area, No. 18 Hengshan Road, Xiangfang District Harbin, Heilongjiang Province, P.R.C. Dear Mr. Wang,Employment Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
Thank you for the opportunity to be of service to you. This letter outlines the terms of our engagement, as we understand them. The term of the employment hereunder shall commence upon signing of this letter. Please indicate your agreement by signing in the space provided at the end of this letter and returning the original to us.
Supplement Agreement to the Equity Transfer AgreementSupplement Agreement to the Equity Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
With respect to the Supplement Agreement to Equity Transfer Agreement executed by the Parties dated February 23, 2010 which provides that the Transferee purchases 100% of the equity interest of Harbin Yew Science and Technology Development Co., Ltd (the “Equity Transfer Agreement”), the Parties reach this supplement agreement as follows:
Lease ContractLease Contract • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
This Contract is enacted according to “Contract Law of the People’s Republic of China” and the Parties hereby agreed as follows:
Debtor’s and Creditors’ Rights Transfer AgreementDebtor’s and Creditors’ Rights Transfer Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
Whereas, Party A, Party B and Party C have separately entered into an Equity Transfer Agreement (the “Equity Transfer Agreement”) with Party D according to which Party D shall purchase all the equity interest held by Party A, Party B and Party C in Harbin Yew Science and Technology Development Co., Ltd.
Supplemental Agreement to the Equity Transfer AgreementSupplemental Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
This Supplemental Agreement (hereinafter referred to as this “Agreement”) is made and entered into by and between the following parties on February 16, 2011 in Harbin, the People’s Republic of China.
Lease ContractLease Contract • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
This Contract is enacted according to “Contract Law of the People’s Republic of China” and the Parties hereby agreed as follows:
Yew Planting Seedlings Transfer ContractYew Planting Seedlings Transfer Contract • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
Party A and Party B, through equal and voluntary negotiation, in accordance with the Forest Law of the People’s Republic of China and other relevant laws and regulations, based on the principles of equal value exchange, enter into this Contract.
Exclusive Business Cooperation AgreementExclusive Business Cooperation Agreement • May 8th, 2012 • Yew Bio-Pharm Group, Inc.
This Exclusive Business Cooperation Agreement (this “Agreement”) is made and entered into by and between the following parties on November 5, 2010 in Harbin, the People’s Republic of China (“China” or the “PRC”).
